{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:59:47Z","timestamp":1779375587722,"version":"3.53.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Martha McCrory Professorship","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"crossref","award":["K23 AR061439"],"award-info":[{"award-number":["K23 AR061439"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"crossref","award":["1R01 AR073208-01"],"award-info":[{"award-number":["1R01 AR073208-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015629","name":"Jerome L Greene Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10067-019-04863-0","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T23:02:37Z","timestamp":1576796557000},"page":"1199-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1)"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1139-2009","authenticated-orcid":false,"given":"Christopher A.","family":"Mecoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Van Eyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Allmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Zeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick M.","family":"Wigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Hummers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"4863_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/ard.53.8.540","volume":"53","author":"AL Herrick","year":"1994","unstructured":"Herrick AL, Heaney M, Hollis S, Jayson MI (1994) Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis 53:540\u2013542","journal-title":"Ann Rheum Dis"},{"key":"4863_CR2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/art.1780350614","volume":"35","author":"FM Wigley","year":"1992","unstructured":"Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ (1992) Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 35:688\u2013693","journal-title":"Arthritis Rheum"},{"key":"4863_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/acr.22978","volume":"69","author":"ZH McMahan","year":"2016","unstructured":"McMahan ZH, Wigley FM, Casciola-Rosen L (2016) Increased risk of digital vascular events in scleroderma patients who have both anti-centromere and anti-interferon-inducible protein 16 antibodies. Arthritis Care Res 69:922\u2013926","journal-title":"Arthritis Care Res"},{"key":"4863_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3899\/jrheum.080516","volume":"36","author":"LK Hummers","year":"2009","unstructured":"Hummers LK, Hall A, Wigley FM, Simons M (2009) Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol 36:576\u2013582","journal-title":"J Rheumatol"},{"issue":"2 Suppl 65","key":"4863_CR5","first-page":"S46","volume":"29","author":"V Riccieri","year":"2011","unstructured":"Riccieri V, Stefanantoni K, Vasile M, Macri V, Sciarra I, Iannace N et al (2011) Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 29(2 Suppl 65):S46\u2013S52","journal-title":"Clin Exp Rheumatol"},{"key":"4863_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/rheumatology\/ken100","volume":"4","author":"J Wipff","year":"2008","unstructured":"Wipff J, Avouac J, Borderie D, Zerkak D, Lemarechal H, Kahan A et al (2008) Disturbed angiogenesis in systemic sclerosis: High levels of soluble endoglin. Rheumatology (Oxford, England) 4:972\u2013975","journal-title":"Rheumatology (Oxford, England)"},{"issue":"4 Suppl 91","key":"4863_CR7","first-page":"S127","volume":"33","author":"I Silva","year":"2015","unstructured":"Silva I, Teixeira A, Oliveira J, Almeida I, Almeida R, Vasconcelos C (2015) Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients. Clin Exp Rheumatol 33(4 Suppl 91):S127\u2013S130","journal-title":"Clin Exp Rheumatol"},{"key":"4863_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10067-013-2354-8","volume":"33","author":"M Ciurzynski","year":"2014","unstructured":"Ciurzynski M, Bienias P, Irzyk K, Kostrubiec M, Bartoszewicz Z, Siwicka M et al (2014) Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis. Clin Rheumatol 33:83\u201389","journal-title":"Clin Rheumatol"},{"key":"4863_CR9","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s10067-016-3219-8","volume":"35","author":"I Silva","year":"2016","unstructured":"Silva I, Almeida C, Teixeira A, Oliveira J, Vasconcelos C (2016) Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis. Clin Rheumatol 35:1743\u20131751","journal-title":"Clin Rheumatol"},{"key":"4863_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/annrheumdis-2011-200143","volume":"71","author":"J Avouac","year":"2012","unstructured":"Avouac J, Meune C, Ruiz B, Couraud PO, Uzan G, Boileau C, Kahan A, Chiocchia G, Allanore Y (2012) Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Ann Rheum Dis 71:394\u2013399","journal-title":"Ann Rheum Dis"},{"key":"4863_CR11","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/ar596","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S et al (2002) Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 4:R11","journal-title":"Arthritis Res"},{"key":"4863_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/1756-185X.12130","volume":"16","author":"HM Farouk","year":"2013","unstructured":"Farouk HM, Hamza SH, El Bakry SA, Youssef SS, Aly IM, Moustafa AA et al (2013) Dysregulation of angiogenic homeostasis in systemic sclerosis. Int J Rheum Dis 16:448\u2013454","journal-title":"Int J Rheum Dis"},{"key":"4863_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","volume":"43","author":"M Hebbar","year":"2000","unstructured":"Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B (2000) Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum 43:889\u2013893","journal-title":"Arthritis Rheum"},{"key":"4863_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5301\/jsrd.5000232","volume":"2","author":"J Seibold","year":"2017","unstructured":"Seibold J, Wigley F, Schiopu E, Denton C, Silver R, Steen V et al (2017) Digital ulcers in SSc treated with oral treprostinil: a randomized, double-blind, placebo-controlled study with open-label follow-up. J Scleroderma Relat Disord 2:42\u201349","journal-title":"J Scleroderma Relat Disord"},{"key":"4863_CR15","doi-asserted-by":"publisher","first-page":"R54","DOI":"10.1186\/ar4216","volume":"15","author":"AA Shah","year":"2013","unstructured":"Shah AA, Schiopu E, Hummers LK, Wade M, Phillips K, Anderson C et al (2013) Open label study of escalating doses of oral treprostinil diethanolamine in patients with systemic sclerosis and digital ischemia: pharmacokinetics and correlation with digital perfusion. Arthritis Res Ther 15:R54","journal-title":"Arthritis Res Ther"},{"key":"4863_CR16","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3899\/jrheum.151437","volume":"43","author":"AA Shah","year":"2016","unstructured":"Shah AA, Schiopu E, Chatterjee S, Csuka ME, Frech T, Goldberg A et al (2016) The recurrence of digital ulcers in patients with systemic sclerosis after discontinuation of oral treprostinil. J Rheumatol 43:1665\u20131671","journal-title":"J Rheumatol"},{"key":"4863_CR17","doi-asserted-by":"publisher","first-page":"19009","DOI":"10.3390\/ijms160819009","volume":"16","author":"I Herraiz","year":"2015","unstructured":"Herraiz I, Sim\u00f3n E, G\u00f3mez-Arriaga PI, Mart\u00ednez-Moratalla JM, Garc\u00eda-Burguillo A, Jim\u00e9nez EA et al (2015) Angiogenesis-related biomarkers (sFlt-1\/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration. Int J Mol Sci 16:19009\u201319026","journal-title":"Int J Mol Sci"},{"key":"4863_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.preghy.2013.02.003","volume":"3","author":"L De Oliveira","year":"2013","unstructured":"De Oliveira L, Pera\u00e7oli JC, Pera\u00e7oli MT, Korkes H, Zampieri G, Moron AF et al (2013) sFlt-1\/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia. Pregnancy Hypertens 3:191\u2013195","journal-title":"Pregnancy Hypertens"},{"key":"4863_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K (2011) Multivariate imputation by chained equations in R. J Stat Softw 45:1\u201367","journal-title":"J Stat Softw"},{"key":"4863_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/sam.11348","volume":"10","author":"F Tang","year":"2017","unstructured":"Tang F, Ishwaran H (2017) Random forest missing data algorithms. Stat Anal Data Min 10:363\u2013377","journal-title":"Stat Anal Data Min"},{"key":"4863_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10994-014-5451-2","volume":"99","author":"H Ishwaran","year":"2015","unstructured":"Ishwaran H (2015) The effect of splitting on random forests. Mach Learn 99:75\u2013118","journal-title":"Mach Learn"},{"key":"4863_CR22","doi-asserted-by":"crossref","unstructured":"Ishwaran H, Lu M (201920) Standard errors and confidence intervals for variable importance in random forest regression, classification, and survival. Stat Med 38:558\u2013582","DOI":"10.1002\/sim.7803"},{"key":"4863_CR23","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/art.24333","volume":"60","author":"AL Herrick","year":"2009","unstructured":"Herrick AL, Roberts C, Tracey A, Silman A, Anderson M, Goodfield M, McHugh N, Muir L, Denton CP (2009) Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis Rheum 60:878\u2013882","journal-title":"Arthritis Rheum"},{"key":"4863_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10067-013-2460-7","volume":"33","author":"M Baron","year":"2013","unstructured":"Baron M, Chung L, Gyger G, Hummers LK, Khanna D, Mayes MD (2013) Consensus opinion of a North American working group regarding the classification of digital ulcers in systemic sclerosis. Clin Rheumatol 33:207\u2013214","journal-title":"Clin Rheumatol"},{"key":"4863_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","volume":"16","author":"Y Mostmans","year":"2017","unstructured":"Mostmans Y, Cutolo M, Giddelo C, Decuman S, Melsens K, Declercq H, Vandecasteele E, de Keyser F, Distler O, Gutermuth J, Smith V (2017) The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review. Autoimmun Rev 16:774\u2013786","journal-title":"Autoimmun Rev"},{"key":"4863_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77","journal-title":"BMC Bioinformatics"},{"key":"4863_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-642-04898-2_150","volume-title":"Bootstrap methods. International encyclopedia of statistical science","author":"MR Chernick","year":"2011","unstructured":"Chernick MR, Gonz\u00e1lez-Manteiga W, Crujeiras RM, Barrios EB (2011) Bootstrap methods. International encyclopedia of statistical science. Springer, Berlin, Heidelberg, pp 169\u2013174"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04863-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04863-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:46:39Z","timestamp":1608252399000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04863-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4863"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04863-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"9 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Two authors (AGA and YR) are employees of United Therapeutics as denoted above. The authors otherwise declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent to participate in the study was obtained from all participants. The Johns Hopkins IRB approved of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}